Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

NCT01783522 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Research Cancelled

Conditions

Chemotherapeutic Agent Toxicity
Multiple Myeloma
Peripheral Neuropathy

Interventions

DRUG: glutamine
OTHER: quality-of-life assessment
OTHER: placebo

Sponsor

Beth Faiman

Collaborators

[object Object]